Terumo Corporation (4543)

Name: Terumo Corporation (4543) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.

Cifras clave

Capitalización bursátil: JPY 3.31 trillion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 1.13T
Beneficio neto: JPY 135.9B
Margen bruto: 52.5%
Margen neto: 12.0%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Ingresos totales	JPY 1.13T	JPY 1.04T	JPY 921.9B	JPY 820.2B	—
Beneficio bruto	JPY 594.7B	JPY 560.7B	JPY 479.2B	JPY 417.4B	—
Ingresos operativos (EBIT)	JPY 176.3B	JPY 157.7B	JPY 140.1B	JPY 117.3B	—
Ingresos netos	JPY 135.9B	JPY 117.0B	JPY 106.4B	JPY 89.3B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4543. /companies/us/4543

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.